Skip to main content

Ultrasonography as a Guiding Method in Breast Micro-Calcification Vacuum-Assisted Biopsies.

Keränen AK, Haapea M, Rissanen T

Publication: Ultraschall Med (2015)PMID: 26200720View on PubMed

Purpose

This paper investigated if diagnosis of a malignancy was associated with the size of the microcalcification cluster or ultrasound abnormalities and compared the sensitivity, specificity, and accuracy for malignancies of ultrasound-guided (US) and stereotactic-guided (S) vacuum-assisted biopsies (VAB) of breast microcalcifications.

Conclusion

A diagnosis of malignancy was more frequent when abnormalities were observed on ultrasound and when the microcalcification clusters were greater than or equal to 3 cm. US-VAB demonstrated higher sensitivity (97% versus 83%) and accuracy (98% versus 94%) compared to S-VAB, but was comparable in specificity (100%, both).  

Studies (1)

Purpose

This study investigated if diagnosis of a malignancy was associated with the size of the microcalcification cluster or ultrasound abnormalities and compared the sensitivity, specificity, and accuracy for malignant diagnoses of US-VAB and S-VAB of breast microcalcifications. One hundred fifty-eight patients with microcalfications not associated with mammographically- or palpatation-identified masses underwent VAB with an 11-gauge probe. The choice of using a mammography add on SVAB device (109 cases) or ultrasound (49 cases) for the biopsy was determined by one of the four radiologists and depended on the characteristics of the tissue (i.e., density, size, visibility of calcification) and the experience of the radiologist.  Small lesions without ultrasound abnormalities made up a larger proportion of S-VAB than US-VAB (49% versus 10%).  After histology, the diagnosis was characterized as malignant (invasive ductal carcinoma, ductal carcinoma in situ, or invasive lobular carcinoma), high risk (atypical ductal hyperplasia, flat epithelial atypia, lobular carcinoma in situ, or atypical lobular hyperplasia) or benign. Surgical resection data was available for all malignant and high-risk diagnoses and benign diagnoses were followed up with imaging. 

Summary of Findings

Eighty of the 158 cases (51%) had abnormalities (i.e., dilated ducts, architectural distortions, a cyst or a mass) observed on ultrasound, with the remaining 78 cases appearing to be normal. As expected, abnormality on ultrasound was more common in microcalcifications diagnosed as malignant (62%) than those diagnosed as benign (37%) or high risk (39%) and clusters of microcalcification greater than or equal to 3 cm were more likely to be malignant than small clusters that were less than or equal to 1 cm (76% versus 32%). Ultrasound abnormalities were correlated with the BI-RADS categories (p<0.001).

More US-VAB than S-VAB were malignant (61% versus 40%) and fewer were high-risk (12% versus 28%). US-VAB demonstrated higher sensitivity (97% versus 83%) and accuracy (98% versus 94%) compared to S-VAB, but was comparable in specificity (100%, both). Of the 10 false negatives, one was from US-VAB and eight from S-VAB.

 

  • Biospecimens

    TissueBreast
  • Preservation Types

    FormalinNone (Fresh)
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticBenign
  • Platforms

    MorphologyH-and-E microscopy
    MorphologyX-ray
    MorphologyLight microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPrognostic factor
    Calcification clusters of 1.1-2.9 cm
    Calcification clusters of ≤1 cm
    Calcification clusters of ≥3 cm
    Ultrasound abnormalities absent
    Ultrasound abnormalities present
    Biospecimen AcquisitionMethod of tissue acquisition
    Sterotactic-guided biopsy
    Ultrasound-guided biopsy